http://www.reportbuyer.com/rss.htmlFind the information you need. Our catalogue of Life Science Technology Reports include Cytogenetics, Imaging Markets and BioMEMS. en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/stem_cell_markets.htmlA stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. 392d4c0c9cfb7970d00d4f1b74c2f8a4Sat, 06 Jun 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/global_medical_imaging_equipment_market_2008_2012.htmlThe medical imaging equipment market comprises devices that are used to create images of parts of the human body for medical purposes such as diagnosis of the diseases and its treatment or for educational purposes. The main equipment are Ultrasound imaging equipment, Computed Tomography Scanners, X-ray machines, Positron Emission Tomography Scanners, Magnetic Resonance Imaging Scanners, Gamma Cameras, Electron Microscope, etc. All over the world, the spending on medical equipment has increased considerably. 676a92223cbd80f6d17e2596553ef08dSat, 06 Jun 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/companion_biomarkers_drug_development.htmlThe term ""companion biomarker"" means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have long played an important role in diagnostic medicine as evidenced by the intense use of specific clinical laboratory tests in the diagnosis of disease. Biomarkers can be used in five very distinct ways in drug development: 1) companion biomarkers can be correlated with biological events during drug development in order to validate drug targets or to predict drug response; 2) biomarkers can be used as companion diagnostics in drug development to characterize patient populations in order to better understand the extent to which new drugs reach intended therapeutic targets can alter proposed therapeutic pathways and achieve successful clinical outcomes; 3) biomarkers can be used to stratify patient populations for drug response in primary prevention or disease-modification studies, particularly in specific clinical areas such as neuron degeneration and cancer; 4) clinically useful biomarkers are becoming increasingly useful to make proper therapeutic decisions regarding candidate drugs; and 5) clinically useful biomarkers are becoming increasingly required by the FDA and other outside authorities to make proper regulatory decisions regarding candidate drugs. cd8b73fa50179563f5d11860358b407aSat, 04 Apr 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/biosimilars.htmlBiosimilars, biogenerics or follow-on biologics - by any name, second generation versions of blockbuster biologic products are coming to America and they are going to have a profound impact on all aspects of the pharmaceutical industry. Now, VOI Consulting, publisher of PharmaHandbook and GenericHandbook, is offering Biosimilars: Problems, Prospects and Projections, a single-source analysis of this fast-moving topic, for immediate download. For only $337, this 55-page PDF report, written in April 2009, provides current information on the economic, manufacturing, regulatory, legislative, competitive and marketing issues that make biosimilars such a lucrative but challenging opportunity. 1584a4cc8024fce5caad8a2beda563e0Sat, 04 Apr 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/technological_advances_microscopy.htmlRapid Strides in Technology Boost the Microscopy Industry Technological developments in the field of microscopy have resulted in the in vivo imaging of live cells and tissues. A growing interest in nanotechnology has led manufacturers to develop sophisticated equipment that integrate advanced software and miniaturization. Digitization of microscopes has brought with it increased resolution, greater precision, and less distorted images. 0fb106fc4f254fb2f858fdb1c06f41f2Tue, 03 Mar 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/north_american_biolubricants_markets.htmlThis study focuses on the Biolubricants Market in North America. Apart from providing industry trends such as drivers, restraints, challenges, unit shipment forecasts and competitive, it provides an opportunity analysis of key application areas based on their current penetration. In addition, future penetration levels have also been provided for various applications and sub applications. 181b3d9a6f6ab08851d3ae80b431de04Mon, 02 Feb 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/bioinformatics_market_potential.htmlBioinformatics and computational biology involve the use of techniques including applied mathematics, informatics, statistics, computer science, artificial intelligence, chemistry, and biochemistry to solve biological problems usually on the molecular level. Research in computational biology often overlaps with systems biology. Major research efforts in the field include sequence alignment, gene finding, genome assembly, protein structure alignment, protein structure prediction, prediction of gene expression and protein-protein interactions, and the modeling of evolution. 178fc5fd6a9fb0fd3a91a4ee27bbe4f8Thu, 01 Jan 2009 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/rna_interference_markets.htmlSince its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry analysts predict that RNA interference (RNAi) may even surpass PCR as a top technology. RNAi allows scientists to silence the expression or effect of a gene under study. 9dc40377058a8eaed72b3f7d466e5623Fri, 12 Dec 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/strategic_analysis_energy_efficient_lamps_market_north_america.htmlThe study provides insight into current trends and dynamics in the Energy Efficient Lamps Market in North America. The scope of the study covers residential, commercial, industrial and public and outdoor end-user segments in the United States and Canada. The study elaborates on the individual market segments that includes CFL and LED markets. a136fd51ba7ff7ebb1b7572e36ca39edFri, 12 Dec 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/u_s_microrna_markets_1.htmlThis research service analyzes the market for microRNA products within the United States. The market was divided into the microRNA microarray, microRNA qRT-PCR, microRNA functional analysis and microRNA services segments. Each segment covers market drivers and restraints, competitive structure, market share analysis and revenue forecasts. b462694aaafda56bcfe9f64b41502246Fri, 12 Dec 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/stem_cells_age.htmlCommercialization of stem cells can potentially help to treat an astounding variety of medical conditions. After a slow start, the stem cell age is finally poised to begin, as numerous factors converge to catapult stem cell technology into the medical mainstream. This report considers: The current state of stem cell science and technology Supplies and services Major applications of stem cell science Sources of funding, regulatory hurdles, and the commercial outlook IP challenges, public perception, bioethical concerns, and diversity in policies Stem cell science is on the precipice of becoming big business. 853af544b043682698dc6f0d287f16b7Tue, 11 Nov 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/biotechnology_european_union_trends_investing_country_profiles.htmlBiotechnology is often considered to be one of the key technologies that will help enable the long-term sustainable development of the European Union (EU), particularly in terms of economic growth, environmental protection and public health. At its March 2000 Lisbon summit the European Council endorsed the objective of making the EU ""the most competitive and dynamic knowledge-based economy in the world, capable of sustainable economic growth with more and better jobs and greater social cohesion"". In 2005 the Lisbon Strategy was refocused on economic growth and more and better jobs. f69bc64c2fa0ef9091e22476da58d130Tue, 11 Nov 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/mammography_world_markets.htmlThe women's mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher interest of individual patients and general healthcare consumers to take charge of their own health status. Continuous improvements in technology are resulting in a growing number of new imaging diagnostic tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. 36594acccc9947143605f1d4fc174a93Fri, 10 Oct 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/neurostimulation.htmlThis report analyzes the worldwide markets for Neurostimulation in Millions of US$. The Major product segments analyzed are Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable Pulse Generator (IPG)}, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS). In addition to the above listed product segments, the report analyzes the US market for Neurostimulation by Gastric Electric Stimulators (GES). 2c5b25f71f12a17de8f46ac14bedfa30Fri, 10 Oct 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/hearing_aid_market_report_2008_edition.htmlHearing aid industry is going digital; the digital revolution has changed the structure of the hearing aid industry. The market is following the trend towards open and cosmetically attractive mini-instruments. The low penetration rates represent a significant growth opportunity for the hearing aid manufacturers. 81f653350392e36ff945e99a9410a8a8Fri, 10 Oct 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/microarray_markets.htmlA microarray is an arrangement of miniaturized test sites or ""spots"" on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules-usually DNA or protein-which act as probes for a test sample applied to the array. The surface may be a glass slide, a plastic plate with wells or a polymer bead. 436995adea8cff0d71ed2b8c6b875870Tue, 09 Sep 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_pcr_markets.htmlThe focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the generally-accepted DNA-oriented analytical activities that are currently used today, such as enabling technologies like polymerase chain reaction (PCR). It examines these measurement technology platforms and their reagents and supplies as utilized in biotechnology research, pharmacology and healthcare. 29e7be696dfefe0351c81b4fb6dcde5aMon, 07 Jul 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/genomics_world_markets.htmlGenomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceutical houses have either formed partnerships with genomics firms that began to emerge in the early 1990s or have created in house genomics divisions. 57bb9fc90d482b64cd60e1235fa1eb6aMon, 05 May 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/regenerative_medicine.htmlThis report analyzes the worldwide markets for Regenerative Medicine in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, and Europe. Annual forecasts are provided for each region for the period of 2003 through 2015. 9574b6e2c1f919db9f8e110f48dc2bb2Fri, 04 Apr 2008 12:00:00 GBBiotechnology/Technologieshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/chiral_technology.htmlThis report analyzes the worldwide markets for Chiral Technology in US$ Million. Chiral Technology Enabling Products analyzed are Intermediates, Analytical, and Others. The specific end-use segments discussed are Pharmaceuticals, and Agrochemicals. a72acd81c7956f51b47bf5782a48b245Fri, 04 Apr 2008 12:00:00 GBBiotechnology/Technologies